A Multicenter, Prospective, Phase II Study of TROP-2 ADC in Combination With Toripalimab for Resectable Locally Advanced Oral Squamous Cell Carcinoma
Clinical trial NCT07778368 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07778368
- Sponsor
- Shanghai East Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-08-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.